EXCLUSIVE SUBLICENSE AGREEMENTExclusive Sublicense Agreement • May 15th, 2006 • Advanced Cell Technology, Inc. • Pharmaceutical preparations • Massachusetts
This Exclusive Sublicense Agreement (“Agreement”) is made and entered into as of March 29, 2006 (the “Effective Date”), by and between TranXenoGen, Inc., a Delaware corporation with offices located at 800 Boston Turnpike Rd, Shrewsbury, Massachusetts 01545 (“TXG”), and Advanced Cell Technology, Inc., a Delaware corporation with offices located at 1201 Harbor Bay Parkway, Suite 120, Alameda, California 94502 (“Licensee” or “ACT”) (TXG and Licensee sometimes hereinafter referred to as the “parties”, or individually as a “party”). As set forth below, Brandeis University (the “University”) agrees to be bound by certain provisions of this Agreement.
